The great big Anthos scam

anonymous

Guest
Spinning off an asset for $250M in 2019, taking board and executive positions on the new company, only to sell it back to Novartis in 2025 for $925M has to be one of the biggest scams ever pulled off by Novartis execs. A lot of people just got very rich at NVS's expense. I smell a shareholder lawsuit coming.
 






Here's a moon shot: inflate the selling price 1000x and sell it to the payers without outcomes date. Call it "population health" aka a triple win for Novartis, novartis and novartis.
 






Bimagrumab is easily one of the biggest, if not biggest failures and screw jobs in Novartis history and possibly pharma history. Also circa 2019s. Drug with weight loss that exceeded ozempic + muscle gain. Idiots